Copyright
©The Author(s) 2022.
World J Clin Cases. Dec 26, 2022; 10(36): 13264-13273
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13264
Published online Dec 26, 2022. doi: 10.12998/wjcc.v10.i36.13264
Table 2 The feasibility and safety of prophylactic treatment, n (%)
| Outcome | |
| Stricture rate | 0 (0) |
| Main complication | 1 (7) |
| Procedure-related bleeding | 0 (0) |
| Procedure-related perforation | 0 (0) |
| Newly diagnosed diabetes or aggravation of diabetes | 0 (0) |
| Pepticulcer | 0 (0) |
| Adrenocortical insufficiency | 0 (0) |
| Aggravation of osteoporosis or fracture | 0 (0) |
| Infection | 1 (7) |
| Corticosteroid related mental disorders | 0 (0) |
| Follow-up period (mo), median (range) | 13 (6-28) |
| Residual | 0 (0) |
| Recurrence | 0 (0) |
- Citation: Zhan SG, Wu BH, Li DF, Yao J, Xu ZL, Zhang DG, Shi RY, Tian YH, Wang LS. Oral higher dose prednisolone to prevent stenosis after endoscopic submucosal dissection for early esophageal cancer. World J Clin Cases 2022; 10(36): 13264-13273
- URL: https://www.wjgnet.com/2307-8960/full/v10/i36/13264.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i36.13264